FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:139 July 14, 1994 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Stolinsky, D. C.

Guns in the Home . On page 1157, in line 10 of the letter by Stolinsky and Stolinsky, the correlation coefficient should have been "r = -0.135," not "R = 0.135," as printed. We regret the error.

This article has been cited by other articles:

• Dressler, L. G., Berry, D. A., Broadwater, G., Cowan, D., Cox, K., Griffin, S., Miller, A., Tse, J., Novotny, D., Persons, D. L., Barcos, M., Henderson, I. C., Liu, E. T., Thor, A., Budman, D., Muss, H., Norton, L., Hayes, D. F. (2005). Comparison of HER2 Status by Fluorescence in Situ Hybridization and Immunohistochemistry to Predict Benefit From Dose Escalation of Adjuvant Doxorubicin-Based Therapy in Node-Positive Breast Cancer Patients. JCO 23: 4287-4297 [Abstract] [Full Text]  
• Shenkier, T., Weir, L., Levine, M., Olivotto, I., Whelan, T., Reyno, L. (2004). Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ 170: 983-994 [Abstract] [Full Text]  
• Adams, V. R, Brenner, T. L (1999). Oprelvekin (Neumega(R)). J Oncol Pharm Pract 5: 117-124 [Abstract]